Pharmacy Times interviews Tracey Taveira, Pharm.D., CDOE, CVDOE, on the key challenges she discovered in optimizing cardio-renal risk in diabetes that she presented in ADA 2026.
Tracey Taveira, Pharm.D., CDOE, CVDOE
Advertisement
Articles by Tracey Taveira, Pharm.D., CDOE, CVDOE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
How the Chai Discovery–Eli Lilly Collaboration Could Advance the Future of AI-Driven Biologics Development
2
First-Ever Guideline on Cardio-Kidney-Metabolic Syndrome Calls for Earlier Screening, Coordinated Care
3
Peptide Therapy for Weight Loss: Separating Clinical Promise From Social Media Hype
4
NLA 2026 Preview: What Pharmacists Need to Know About Lipid Science, PCSK9 Data, and Pediatric Cardiometabolic Risk
5